TABLE 2.
Removal of borreliacidal antibodies from Lyme disease sera after adsorption with OspC-Dra, C16, and C7
| Serum sample | Borreliacidal activitya after adsorption with:
|
|||
|---|---|---|---|---|
| Untreated | OspC-Dra | C16 | C7 | |
| Controlb | 5,120 | 5,120 | 5,120 | 5,120 |
| 1 | 10,240 | ND | ND | ND |
| 2 | 40,960 | ND | ND | ND |
| 3 | 10,240 | ND | ND | ND |
| 4 | 10,240 | ND | ND | ND |
| 5 | 2,560 | ND | ND | ND |
a
Reciprocal of last dilution with significant borreliacidal activity. ND, no borreliacidal activity detected.
b
Lyme disease serum containing OspA and OspB borreliacidal antibodies.